Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
TKNO US Equity
Alpha Teknova, Inc.
8.70USD▼ 1.58%
Healthcare
Drug Manufacturers - Specialty & Generic
96)Comparar97)Tesis →
Market Cap
$467M
Shares Outstanding
54M
Revenue (TTM)
$44M
Net Income (TTM)
−$17M
FCF (TTM)
−$7M
— Annual —FY2025
Revenue
$41M
Gross Margin
33.2%
Operating Margin
-41.9%
Net Margin
-42.6%
FCF Margin
-24.2%
ROE
-25.1%
ROCE
-17.7%
Net Debt/EBITDA
-0.7×
Current Ratio
4.58
D/E Ratio
0.19
FCF / Share
-0.18
Book Value / Share
1.28
TKNO US Equity
8.70USD▼ 1.58%
Tesis →

Alpha Teknova, Inc. (TKNO): análisis fundamental y valoración

Alpha Teknova, Inc. cotiza a 8.70 USD y tiene una capitalización bursátil de $467M. En los últimos 12 meses ha facturado $44M con un margen de flujo de caja libre del -24.2%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados158Beta0.86Web↗ www.teknova.com

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
11.7×
P/Sales
11.5×
P/Book
6.8×
Rentabilidad (Último Anual)
Gross Margin
33.2%
Operating Margin
-41.9%
Net Margin
-42.6%
FCF Margin
-24.2%
ROE
-25.1%
ROCE
-17.7%
ROA
-16.7%
Effective Tax Rate
—
Métricas TTM
Revenue TTM
$44M
Gross Profit TTM
$15M
Operating Income TTM
−$16M
Net Income TTM
−$17M
FCF TTM
−$7M
EPS TTM
-0.3
Quarters Used
4
TTM Period
2025-09-30 → 2026-06-30
Solidez del Balance
Net Debt
$7M
Net Debt / EBITDA
-0.7×
Debt / Equity
0.19
Current Ratio
4.58
Interest Coverage
—
Working Capital
$27M
Book Value / Share
1.28
Net Debt / Share
0.13
Crecimiento (YoY)
Revenue YoY
+7.3%
Net Income YoY
+35.5%
FCF YoY
+27.5%
EPS Diluted YoY
+43.9%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-0.18
CapEx % Revenue
2.8%
Rev / Employee
256,455
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaTKNOMediana SectorΔ
Gross Margin33.2%57.0%-23.9%
Operating Margin-41.9%-38.6%-3.3%
Net Margin-42.6%-33.6%-9.0%
FCF Margin-24.2%-13.9%-10.3%
ROE-25.1%-40.4%+15.3%
ROA-16.7%-32.0%+15.3%
Current Ratio4.582.84+1.74
Debt / Equity0.190.28-0.09
Scoring Fundamental
Capital Allocation
3/ 8Débil
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✗DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)